Canada markets closed

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
115,700.00-1,400.00 (-1.20%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) 1.32T
Enterprise Value 2.07T
Trailing P/E 21.15
Forward P/E 17.54
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.81
Price/Book (mrq)1.05
Enterprise Value/Revenue 1.27
Enterprise Value/EBITDA 28.82

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 30.61%
S&P500 52-Week Change 323.76%
52 Week High 3131,100.00
52 Week Low 393,000.00
50-Day Moving Average 3114,458.00
200-Day Moving Average 3113,967.00

Share Statistics

Avg Vol (3 month) 318.69k
Avg Vol (10 day) 322.44k
Shares Outstanding 511.41M
Implied Shares Outstanding 611.42M
Float 85.45M
% Held by Insiders 151.45%
% Held by Institutions 112.49%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41500
Forward Annual Dividend Yield 41.30%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.96
Payout Ratio 41,080.25%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 27, 2023
Last Split Factor 21.05:1
Last Split Date 3Jun 07, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -1.81%
Operating Margin (ttm)-4.21%

Management Effectiveness

Return on Assets (ttm)0.77%
Return on Equity (ttm)-1.88%

Income Statement

Revenue (ttm)1.63T
Revenue Per Share (ttm)143,165.36
Quarterly Revenue Growth (yoy)2.10%
Gross Profit (ttm)N/A
EBITDA 110.1B
Net Income Avi to Common (ttm)-29.49B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.79B
Total Cash Per Share (mrq)5,676.75
Total Debt (mrq)813.03B
Total Debt/Equity (mrq)54.41%
Current Ratio (mrq)1.38
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-32.19B
Levered Free Cash Flow (ttm)-151.89B